This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2020 Jul 11;396(10244):93-94.

doi: 10.1016/S0140-6736(20)30479-7.

Differential effect of ticagrelor on irreversible harms in diabetes - Authors' reply

Deepak L Bhatt¹, Philippe Gabriel Steg²

Affiliations

Affiliations

¹ Brigham and Women's Hospital Heart and Vascular Center and Harvard Medical School Boston, MA 02115, USA. Electronic address: dlbhattmd@post.harvard.edu.
² French Alliance for Cardiovascular Trials, Département Hospitalo-Universitaire FIRE, AP-HP, Hôpital Bichat, Université de Paris, Institut National de la Santé et de la Recherche Médicale, Paris, France; National Heart and Lung Institute, Imperial College, Royal Brompton Hospital, London, UK.

PMID: 32653065
DOI: 10.1016/S0140-6736(20)30479-7

Comment

Differential effect of ticagrelor on irreversible harms in diabetes - Authors' reply

Deepak L Bhatt et al. Lancet. 2020.

. 2020 Jul 11;396(10244):93-94.

doi: 10.1016/S0140-6736(20)30479-7.

Authors

Deepak L Bhatt¹, Philippe Gabriel Steg²

Affiliations

¹ Brigham and Women's Hospital Heart and Vascular Center and Harvard Medical School Boston, MA 02115, USA. Electronic address: dlbhattmd@post.harvard.edu.
² French Alliance for Cardiovascular Trials, Département Hospitalo-Universitaire FIRE, AP-HP, Hôpital Bichat, Université de Paris, Institut National de la Santé et de la Recherche Médicale, Paris, France; National Heart and Lung Institute, Imperial College, Royal Brompton Hospital, London, UK.

PMID: 32653065
DOI: 10.1016/S0140-6736(20)30479-7

No abstract available

PubMed Disclaimer

Comment on

Differential effect of ticagrelor on irreversible harms in diabetes.
Chi G, Marszalek J. Chi G, et al. Lancet. 2020 Jul 11;396(10244):93. doi: 10.1016/S0140-6736(20)30486-4. Lancet. 2020. PMID: 32653064 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information